2004 Annual Meeting | Controversies in Critical Care of Brain Hemorrhage

Date Saturday 05/01/04

Time 06:45 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Breakfast Seminar

Director(s) Paul M. Vespa, MD, FAAN

Topic(s) Critical Care

Learning Objectives Upon completion:
Participants should be updated on current treatment guidelines and recommendations and be able to implement updated information into real-life cases.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident

Event Timeline
06:45 AM - 07:15 AM		Innovative Medical Treatments for Brain Hemorrhage Stephan A. Mayer, MD
07:15 AM - 08:00 AM		Titration of Blood Pressure After ICH Claude Hemphill III, MD, FAAN
08:00 AM - 08:30 AM		Minimally Invasive Treatments of Brain Hemorrhage Paul M. Vespa, MD, FAAN

Faculty Disclosures
Claude Hemphill III, MD, FAAN	Dr. Hemphill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Hemphill has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Hemphill has received research support from NIH/NINDS.
Paul M. Vespa, MD, FAAN	Dr. Vespa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ceribell. Dr. Vespa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ceribell. Dr. Vespa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ceribell. Dr. Vespa has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. The institution of Dr. Vespa has received research support from NIH. Dr. Vespa has received intellectual property interests from a discovery or technology relating to health care.
Stephan A. Mayer, MD	Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astra Zeneca. Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Mayer has stock in Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��